Skip to main content
TipRanks
Go Ultimate75% OFF

Kane Biotech (KNE) Income Statement

2 Followers

Kane Biotech Income Statement

Last quarter (Q2 2026), Kane Biotech's total revenue was C$8.14K, a decrease of 70.92% from the same quarter last year. In Q2, Kane Biotech's net income was C$-833.64K. See Kane Biotech’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementMar 26Mar 25Dec 23Mar 23Dec 21
C$ 427.87KC$ 2.08MC$ 148.98KC$ 156.73KC$ 1.61M
C$ -163.38KC$ 872.10KC$ 109.47KC$ 1.41MC$ 568.44K
C$ 2.95MC$ 4.80MC$ 3.47MC$ 4.78MC$ 5.45M
Depreciation and AmortizationC$ 162.74KC$ 218.47KC$ 238.59KC$ 257.68KC$ 187.97K
C$ -2.95MC$ -3.71MC$ -3.11MC$ -2.95MC$ -4.25M
C$ -3.11MC$ -4.49MC$ -3.36MC$ -3.46MC$ -4.88M
C$ 283.08KC$ 22.60KC$ -1.20MC$ -564.03KC$ 33.65K
C$ -2.83MC$ -4.47MC$ -4.56MC$ -4.02MC$ -4.85M
C$ -2.72MC$ -3.02MC$ -5.03MC$ -3.89MC$ -4.60M
Per Share Metrics
Basic EPSC$ -0.02C$ -0.02C$ -0.04C$ -0.03C$ -0.04
Diluted EPSC$ -0.02C$ -0.02C$ -0.04C$ -0.03C$ -0.04
Weighted Average Shares Outstanding162.22M133.91M127.12M120.70M112.60M
Weighted Average Shares Outstanding (Diluted)162.22M133.91M127.12M120.70M112.60M

Currency in CAD

Kane Biotech Earnings and Revenue History

-6M-3M03M-3600 %-2400 %-1200 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin